Given that the variant allele frequency of the myeloproliferative neoplasm-associated driver mutations (JAK2) was higher than that of the non-driver mutations in two of these cases, it is possible ...

The 2001 World Health Organization (WHO)-sponsored classification of hematopoietic tumors has, for the first time, clearly defined a group of rare myeloid neoplasms termed myelodysplastic ...

The myeloproliferative neoplasms (MPNs) polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) are hematopoietic neoplasms with characteristic driver mutations in most cases ...

The COMBI study, a prospective, open‐label, ... Combination Therapy With Interferon Alfa-2 and Ruxolitinib Shows Promise in Treating Myeloproliferative Neoplasms. Author(s): ...